ArticleBioengineering (Basel, Switzerland)2025
A Collaborative Data Sharing Platform to Accelerate Translation of Biomedical Innovations.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Recent advances in multimodal foundation model-enabled peptide screening and optimization for smart biomaterials and functional tissue engineering.Frontiers in bioengineering and biotechnology · 2026Review
- From algorithms to clinical execution: A cross-validated knowledge atlas of AI-enabled precision care (2015-2025).Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
This perspective article presents an innovative concept for a biomanufacturing Knowledge Hub (KH), designed as a data-driven learning platform supporting the entire lifecycle of biomedical products. By integrating advanced data sharing and processing technologies, the KH aspires to connect patients, bioengineers, clinicians, regulators, companies, and investors to accelerate product development, reduce redundancies, and ultimately fast-track the delivery of biomedical innovations to patients. We discuss current challenges in accessing and sharing data within biomanufacturing and outline novel approaches for building an ecosystem that links data stores, integrates digital twins, and leverages advanced analytics. The KH offers transformative capabilities, enabling the development of new products at a substantial increased speed. It is built as a secure, quantum-resistant platform that encrypts data and allows access through advanced algorithms, creating an intelligent, collaborative environment. Users can harness collective knowledge to enhance products, launch innovations, integrate technologies, and unlock revenue opportunities based on data quality and usage. This KH aims to revolutionize biomanufacturing, offering unprecedented opportunities for innovation, better patient outcomes, and commercialization with far reaching applications beyond biomanufacturing in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.